Cost-Per-Reportable Results (CPPR) Clinical Laboratory Reagents
ID: HT941024Q2053Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

CHEMICAL ANALYSIS INSTRUMENTS (6630)

Original Source

https://sam.gov/opp/63b4ddd16b5046c6b60f1ba7cdbc07ad/view
Timeline
    Description

    The Department of Defense, Defense Health Agency, seeks clinical laboratory reagents and consumables for clinical chemistry with immunoassay testing at the Naval Health Clinic Lemoore. The CPPR model links reagent costs to reportable results, with the base contract covering 12 months and four 12-month options. Key contacts are CHA-ON Gordon and Kennette Esguerra. Extended questions and answers are due by 10:00 AM Pacific on July 25, 2024, and quotes by 10:00 AM on August 8, 2024.

    The solicitation outlines the need for a comprehensive solution, including analyzers, accessories, and technology, with an emphasis on efficient testing methodologies, quality control, and ongoing training and technical support. This approach aims to streamline operations at the Naval Health Clinic.

    Per the attached Statement of Work, the contract holds potential value of $4 million for the base period, with each option year at $3 million, funded by the Department of Defense. Offerors should respond to the solicitation, with all bids due before the August deadline for consideration.

    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Cost-Per-Reportable Results (CPPR) Clinical Laboratory Reagents
    Currently viewing
    Solicitation
    Similar Opportunities
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting a sources sought announcement to identify local sources capable of providing medical laboratory reagents for the United States Naval Hospital (USNH) in Okinawa, Japan. The procurement involves the delivery of CLASS VIII medical laboratory reagents, including Ortho reagents and consumables compatible with VITROS 5600 Analyzers, along with necessary training and maintenance services for the equipment. This opportunity is critical for ensuring the availability of essential medical supplies and maintaining compliance with healthcare standards in a military setting. Interested parties must submit their qualifications and relevant information by September 30, 2024, to the primary contacts, Bradley Ah Nee and Arlene Renner, via email at bradley.ahnee@dla.mil and arlene.renner@dla.mil, respectively. The estimated contract value is under $5.4 million, covering a base period of 12 months with two optional periods.
    Combined Synopsis/Solicitation to provide quality control (QC) products for testing Clinical Chemistry, and Immunochemistry Testing for the Brooke Army Medical Center (BAMC), JBSA, Fort Sam Houston, TX.
    Active
    Dept Of Defense
    The Department of Defense, through the Department of the Army, is seeking proposals for the supply of quality control (QC) products for Clinical Chemistry and Immunochemistry testing at the Brooke Army Medical Center (BAMC) located at JBSA, Fort Sam Houston, Texas. The procurement includes FDA-approved QC reagents and consumables, alongside a computerized Quality Assurance Program, with a contract period extending from October 2024 to September 2029. These products are critical for maintaining high-quality laboratory testing standards and ensuring patient safety in military health facilities. Interested vendors must submit their offers by September 9, 2024, at 1:00 PM Central Standard Time, and direct any questions by August 30, 2024, to the primary contacts, Medina L. Woodson and Salameya Paulouskaya, via the provided email addresses.
    Microbiology Supplies and Reagents at U.S. Naval Hospital Guam
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified small businesses to provide microbiology supplies and reagents for the U.S. Naval Hospital in Guam. The procurement includes essential quality controls and reagents necessary for laboratory testing operations, with a delivery period from October 1, 2024, to September 30, 2025, and options for four additional years. This acquisition is critical for maintaining public health and ensuring reliable access to diagnostic tools within the military healthcare system. Interested contractors must submit their quotes electronically by 9:00 AM PDT on September 19, 2024, and can direct inquiries to Nicole Ventinilla at nicole.e.ventinilla.civ@health.mil.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    Hematology System Cost Per Reportable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking proposals for the procurement of two fully automated Hematology Systems for the 633rd Medical Group at Langley AFB, Virginia. These systems must perform a range of hematology tests, including complete blood counts and body fluid analyses, while integrating seamlessly with the existing Laboratory Information System (LIS). The contract will be awarded as a firm-fixed-price agreement, with a base year commencing on October 6, 2024, and four additional option years, emphasizing the importance of technical capability and past performance in the evaluation process. Interested vendors must submit their proposals electronically by September 20, 2024, and direct any questions to Karl Molina at karl.o.molina.civ@health.mil by September 12, 2024.
    6640--BLOOD ANALZYERS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the procurement of Point-of-Care Blood Analyzers, including necessary reagents and consumables, to support healthcare services at the VA Long Beach Healthcare System. The contract aims to establish a Blanket Purchase Agreement (BPA) for the supply of 17 analyzers, with potential for additional units, ensuring compliance with stringent technical specifications and quality control measures, including FDA approval for all consumables. This procurement is critical for enhancing the quality of care provided to veterans by facilitating timely blood testing prior to surgeries. Interested vendors must submit their quotes electronically to Contract Specialist Kahlfanie Carabon by September 6, 2024, with the contract structured for a base year plus four optional years, reflecting the VA's commitment to maintaining high standards in medical diagnostics.
    BIORAD DRUG OF ABUSE AND CONTROLS
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Navy through the NAVSUP FLC Sigonella Naples Office, is seeking suppliers for consumable supplies related to drug of abuse and chemistry testing at the US NMRTC Sigonella Laboratory. The procurement requires brand name products that must be delivered within four days of request, as detailed in the attached Statement of Work (SOW). These supplies are critical for conducting essential testing on patients, ensuring timely and accurate results in a laboratory setting. Interested vendors can reach out to Alessandra Pulvir at 314-624-5727 or via email at Alessandra.Pulvir.IT@eu.navy.mil for further information regarding this solicitation.
    6550--FLOW CYTOMETRY REAGENTS AND SUPPLIES BASE PLUS FOUR
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a Blanket Purchase Agreement (BPA) for Flow Cytometry Reagents and Supplies, specifically under solicitation number 36C26225Q0021. This procurement aims to enhance patient care for veterans by acquiring essential testing reagents and supplies, with a focus on compliance with FDA standards and compatibility with existing BD FACS Lyric systems. The BPA will cover a base year plus four optional one-year extensions, with an implementation date targeted for October 1, 2024. Interested vendors must submit their proposals by September 12, 2024, at 12 PM Pacific Time, and can contact Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov for further information.
    BIOMERIEUX REAGENTS AND BLOOD CULTURE BOTTLES
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Navy, is seeking suppliers for laboratory reagents and blood culture bottles necessary for blood testing at the U.S. Navy Hospital in Naples, Italy. The procurement aims to acquire consumable supplies compatible with the Government-owned VITEK@2 Compact and BacT/ALERT@ 3D equipment utilized by the laboratory department. These supplies are critical for ensuring accurate and timely blood testing, which is essential for patient care and medical diagnostics. Interested vendors can reach out to Luca Buonocunto at the provided email or telephone number for further details regarding the solicitation process.
    MEDICAL I-STAT CARTRIDGE
    Active
    Dept Of Defense
    The US Department of Defense, specifically the Defense Logistics Agency Troop Support Pacific, seeks local suppliers capable of fulfilling a critical medical laboratory reagent requirement for the US Naval Hospital in Okinawa, Japan. They aim to establish a regular supply of specific i-STAT cartridges, prioritizing a consistent monthly stock of CG4+ and CGB+ cartridges. The firm-fixed priced contract, estimated under $70,000 including shipping, is contemplated for a base period of 12 months, with an optional extension for a similar period. The delivery schedule is time-sensitive, requiring monthly deliveries to the hospital, with the potential for renewal based on performance. Interested parties should respond with company details and their ability to meet the specific medical cartridge demands, as outlined in the attached delivery schedule.